Clinical Scorecard: Establishing the Concept of Post-Colon Capsule Endoscopy Colorectal Cancer (pCCECRC): A Consensus Statement from the International Capsule Endoscopy Research (iCARE) Group

At a Glance

Key Highlights

• PCCRC refers to colorectal cancer diagnosed after a colonoscopy with no malignancy identified.
• The World Endoscopy Organisation recommends reporting PCCRC within 6 months to 3 years post-colonoscopy.
• Post-CCE colorectal cancer rates have not been systematically reported due to the recent scale-up of CCE services.
• A structured definition for pCCECRC is needed for audit and standardised reporting.
• Quality assurance metrics for colonoscopy are essential for evaluating pCCECRC.
• The need for a structured definition for pCCECRC to enhance clarity.

Guideline-Based Recommendations

Diagnosis

• PCCRC should be reported when cancer is diagnosed between 6 months and 3 years after a clear colonoscopy.

Management

• Standardised reporting supports comparison between CCE services and enhances service evaluation.

Monitoring & Follow-up

• Routine audit of outcomes and defined performance indicators are core components of colonoscopy quality assurance, including specific metrics for pCCECRC.

Risks

• Variation in PCCRC rates reflects differences in colonoscopy quality and service organisation.

Patient & Prescribing Data

Patients undergoing colon capsule endoscopy for colorectal cancer evaluation.

Colonoscopy remains the reference standard, while CCE is a minimally invasive alternative.

Clinical Best Practices

• Implement routine audits of PCCRC rates to ensure quality in colonoscopy services.
• Develop a consensus framework for defining and reporting pCCECRC, emphasizing standardization.

Related Resources & Content

• World Endoscopy Organisation
• British Society of Gastroenterology